Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EOG Resources
EOG
|
+$727M |
| 2 |
Home Depot
HD
|
+$472M |
| 3 |
Pfizer
PFE
|
+$362M |
| 4 |
Texas Instruments
TXN
|
+$314M |
| 5 |
LyondellBasell Industries
LYB
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$567M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$245M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$242M |
| 4 |
AT&T
T
|
+$170M |
| 5 |
Accenture
ACN
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.07% |
| 2 | Financials | 12.97% |
| 3 | Healthcare | 12.01% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
iShares Russell Mid-Cap ETF
IWR
$57.3B
| $820K | ﹤0.01% |
10,500
-2,200
| -17% | -$169K |
|
2927
Miller Industries
MLR
$579M
| $819K | ﹤0.01% |
29,056
+530
| +2% | +$16.3K |
|
2928
EyePoint Inc
EYPT
$978M
| $818K | ﹤0.01% |
67,289
+13,083
| +24% | +$143K |
|
2929
Tarsus Pharmaceuticals
TARS
$2.67B
| $818K | ﹤0.01% |
48,583
+1,402
| +3% | +$26K |
|
2930
Seneca Foods Class A
SENEA
$1.18B
| $817K | ﹤0.01% |
15,854
-30
| -0.2% | -$1.47K |
|
2931
Vera Therapeutics
VERA
$2.15B
| $817K | ﹤0.01% |
34,743
+11,251
| +48% | +$242K |
|
2932
Olema Pharmaceuticals
OLMA
$1.03B
| $816K | ﹤0.01% |
191,531
-11,079
| -5% | -$61.1K |
|
2933
Tenaya Therapeutics
TNYA
$161M
| $810K | ﹤0.01% |
68,704
+33,161
| +93% | +$401K |
|
2934
Rio Tinto
RIO
$161B
| $808K | ﹤0.01% |
10,050
-1,045
| -9% | -$79.3K |
|
2935
Shattuck Labs
STTK
$756M
| $807K | ﹤0.01% |
189,384
-6,992
| -4% | -$39.7K |
|
|
DADA
2936
DELISTED
Dada Nexus
DADA
| $806K | ﹤0.01% |
88,198
+3,562
| +4% | +$34.7K |
|
2937
First Bancorp
FNLC
$402M
| $806K | ﹤0.01% |
26,782
+226
| +0.9% | +$7.06K |
|
2938
Ezcorp Inc
EZPW
$1.91B
| $805K | ﹤0.01% |
133,184
+3,022
| +2% | +$18.8K |
|
2939
Hovnanian Enterprises
HOV
$799M
| $801K | ﹤0.01% |
13,544
+263
| +2% | +$23.8K |
|
2940
Veru
VERU
$38M
| $800K | ﹤0.01% |
16,553
+551
| +3% | +$29.9K |
|
|
DFTX
2941
Definium Therapeutics
DFTX
$5.62B
| $798K | ﹤0.01% |
47,904
-2,055
| -4% | -$35.7K |
|
2942
Electromed
ELMD
$349M
| $796K | ﹤0.01% |
63,922
| – | – |
|
|
KC
2943
Kingsoft Cloud Holdings
KC
$3.92B
| $796K | ﹤0.01% |
130,987
+5,343
| +4% | +$43.5K |
|
|
SCU
2944
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $792K | ﹤0.01% |
56,840
-24,085
| -30% | -$390K |
|
2945
Genie Energy
GNE
$368M
| $791K | ﹤0.01% |
117,185
| – | – |
|
2946
Foghorn Therapeutics
FHTX
$285M
| $790K | ﹤0.01% |
51,870
+1,059
| +2% | +$14.5K |
|
2947
Lifecore Biomedical
LFCR
$163M
| $790K | ﹤0.01% |
68,190
+1,826
| +3% | +$20.3K |
|
2948
Vita Coco
COCO
$3.73B
| $789K | ﹤0.01% |
87,978
+10,098
| +13% | +$106K |
|
2949
InnovAge Holding
INNV
$1.47B
| $789K | ﹤0.01% |
122,745
-53,846
| -30% | -$272K |
|
2950
iRadimed
IRMD
$1.19B
| $788K | ﹤0.01% |
17,553
+690
| +4% | +$31.9K |
|
Similar funds
Charles Schwab's Q1 2022 Portfolio in Review
As of Q1 2022, Charles Schwab held 3,695 positions worth $333B, down 1.7% from $339B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab deployed $10.7B of net new capital in Q1 2022, opening 106 new positions and adding to 2,783 existing holdings. Its largest new stake was Constellation Energy: 1,449,939 shares worth $81.6M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Emerson Electric, an estimated $567M trimmed.
- Charles Schwab's largest Q1 2022 buy was Constellation Energy: 1,449,939 shares worth $81.6M.
- Charles Schwab added most to EOG Resources in Q1 2022, an estimated $727M increase.
- Charles Schwab's biggest Q1 2022 reduction was Emerson Electric, cutting an estimated $567M.
- Charles Schwab fully exited Xilinx Inc in Q1 2022, selling an estimated $245M.
- Charles Schwab's ten largest holdings make up 18% of its $333B portfolio in Q1 2022.
- Charles Schwab opened 106 new positions and closed 115 in Q1 2022.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $333B.
Based on Charles Schwab's 13F filing for Q1 2022, filed 13 May 2022.